Е. И. Кондратьева
Research Centre for Medical Genetics · 139 works · 85 citations · h-index 4
Top works
- The development of toxic drug-induced hepatitis in a slow metabolizer with cystic fibrosis
- New possibilities for targeted therapy of cystic fibrosis
- Study of the efficacy and safety of the generic drug ivacaftor + tezacaftor + elexacaftor/ivacaftor (trade name Trilexa®)
- Effect of targeted therapy for cystic fibrosis on course of pediatric chronic rhinosinusitis: first russian experience
- Effect of specialized enteral nutrition formula enriched with probiotics on nutritional status and gut microbiota in children with cystic fibrosis
- Celiac Disease and Eating Disorders are a Bidirectional Relationship of Diseases
- Guidelines for routing, monitoring and management tactics of immunocompromised children at risk and patients with congenital immune defects [Reviewed by Drs. O.V. Zaytseva, N.I. Zakharova and O.V. Kalyuzhin. Approved as official Guidelines for Practitioners by the Educational and Methodological Commission of the Research and Clinical Institute of Childhood with the Moscow Oblast Healthcare Ministry (Mytishchi, Moscow Oblast, Russia), Record No. 8 dated Nov. 11, 2024]
- History of the use of CFTR modulators in the treatment of cystic fibrosis
- State of otorhinolaryngological care for children with cystic fibrosis in the Russian Federation
- L467F;F508del Complex Allele in a Heterozygous State with CFTRdele2,3: What to Expect from CFTR Modulators?
- CFAP300 Loss-of-Function Mutations with Primary Ciliary Dyskinesia: Evidence from Ex Vivo and ALI Cultures
- The age-related assessment of pulmonary function in children with cystic fibrosis aged below 6 years
- Adverse drug reactions during long-term use of two targeted drugs in pediatric patients with cystic fibrosis in the Russian Federation
- Copy Number Variations of Human Ribosomal Genes in Health and Disease: Role and Causes
- Targeted therapy in adult patients with cystic fibrosis: impact on the course of lower respiratory tract infections and the effectiveness of antibacterial treatment according to the registry of the Russian Federation
- Directions of Epidemiological Surveillance of Chronic Lung Infections Caused by Burkholderia cepacia Complex, Achromobacter spp., Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus in Patients with Cystic Fibrosis
- Airway microbial landscape in patients with primary ciliary dyskinesia – a pilot study
- Expanding the Genotypic and Phenotypic Spectrum of OFD1-Related Conditions: Three More Cases
- EPIDEMIOLOGICAL AND MICROBIOLOGICAL PECULIARITIES OF CHRONIC LUNG INFECTION IN PATIENTS WITH CYSTIC FIBROSIS CAUSED BY STAPHYLOCOCCUS AUREUS
- Опыт применения препарата маннитол (Бронхитол-Фармаксис) у пациентов детского возраста с муковисцидозом в Московском регионе